Stephen Curtis Email & Phone Number

Canton, MA, US

BrightEdge is the impact investment, venture capital, and innovation arm of the American Cancer Society (ACS). We invest in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies that can accelerate the ACS mission to end cancer for all.BrightEdge makes venture capital investments in.

Founding Chief Operating Officer and Board Member. Led early strategy and company building efforts, and business development activities.Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on a novel validated checkpoint axis, with the goal.

Palo Alto, CA, US

Palo Alto, CA, US

Palo Alto, CA, US

The Kauffman Fellows Program is designed to develop a world-wide network of innovation investors who provide smart, connected capital to fuel entrepreneurial change. While working full-time at an investment organization, Fellows receive a structured curriculum with an individual development plan, executive coaching, facilitated mentoring, and peer learning.

Boston, Massachusetts, US

Created four NewCo's that are progressing through their initial seed financing.

Boston, Massachusetts, US

Managed MPM’s investment collaboration with Dana-Farber Cancer Institute and enabled the creation of multiple start-up companies. Also, supported MPM's relationship with multiple strategic partners and collaborators to accelerate the development of MPM portfolio companies.

Boston, Massachusetts, US

Responsible for investment identification, due diligence, business development and new company creation activities.

Waltham, Massachusetts, US

Indianapolis, Indiana, US

The Emerging Technology and Innovation team complements therapeutic area-specific external research efforts by providing distinct geographic coverage plus access to novel pathways and new therapeutic modalities. We specialize in connecting partners to Lilly expertise and deploying flexible funding models. The team comprises experienced drug discovery and.

Dallas, Texas, US

2M Companies is the family office of Morton H. Meyerson and an investment firm focused on the bioscience, technology, and oil/gas industries. 2M is a values-driven organization that invests with people who are interested in effecting social change. The bioscience ventures team invests in innovative, early-stage technologies that can dramatically improve.

Plano, Texas, US

Reata Pharmaceuticals is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing product candidates that modulate the activity of key regulatory proteins involved in the biology of oxidative stress, mitochondrial function, and inflammation to address the unmet medical needs of patients with a variety of serious or.

Forchheim, DE

- Developed market research reports on key healthcare areas of interest for SVC.- Identified experts in the sectors of interest and performed in-person interviews.- Learned investment strategy and valuation models from SVC associates.- Presented reports to the Partners at SVC and made recommendations for future investments.

Boston, MA, US

- Elucidated the role of lung stem cells in the initiation, maintenance, and progression of lung cancer.- Discovered the effect of lung tumor genotype on determining the identity of tumor-propagating cells.- Uncovered cellular markers and molecular pathways important in tumor-propagation and metastasis.

Dublin, Coolock, IE

- Developed methods to correlate dissolution and wetability to bioavailability in vitro and in vivo.

Ithaca, NY, US

- Elucidated the role of dermal stem cells in the initiation and development of soft tissue sarcoma.

Ludwigshafen, DE

- Determined the therapeutic potential of novel MMP inhibitors as anti-angiogenic agents.

Doctor Of Philosophy (Ph.D.), Biological And Biomedical Sciences

Bachelor Of Science (B.S.), Molecular And Cellular Biology; Applied Economics And Management